The Scientist

» data sharing and ecology

Most Recent

image: Intelligence Gathering

Intelligence Gathering

By | July 1, 2015

Disease eradication in the 21st century

0 Comments

image: Ravenous Invasive Worm Now in U.S.

Ravenous Invasive Worm Now in U.S.

By | June 25, 2015

Researchers have found the New Guinea flatworm, one of the world’s most invasive species, in Florida, putting native ecosystems at serious risk.

0 Comments

image: Climate Change Speeds Extinctions

Climate Change Speeds Extinctions

By | May 3, 2015

Species die-offs are expected to accelerate as greenhouse gases accumulate, according to a meta-analysis.

0 Comments

image: Bees Drawn to Pesticides

Bees Drawn to Pesticides

By | April 24, 2015

One study shows the insects prefer food laced with pesticides, while another adds to the evidence that the chemicals are harmful to some pollinators.

0 Comments

image: BRCA Breakthroughs?

BRCA Breakthroughs?

By | April 21, 2015

Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.

0 Comments

image: WHO: Share Trial Data

WHO: Share Trial Data

By | April 15, 2015

The World Health Organization again calls upon researchers to register clinical trial details in freely accessible databases before initiation of the study.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | March 1, 2015

Evolving Ourselves, The Man Who Touched His Own Heart, Bats, and The Invaders

1 Comment

image: Sharing Longevity Data

Sharing Longevity Data

By | March 1, 2015

Aging research would greatly benefit from consistently making annotated life span data available.

0 Comments

image: Ebola Drug Trial Canceled

Ebola Drug Trial Canceled

By | February 2, 2015

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

0 Comments

image: Tamiflu Reviewed Again

Tamiflu Reviewed Again

By | January 30, 2015

The controversial antiviral drug earns better marks in the most recent analysis of the evidence. 

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech